跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 164 条关于
“Shank3”
全部
164
临床试验
98
药物
25
机构
16
资讯
25
去年
Neuren Pharmaceuticals Launches First-Ever Phase 3 Trial for Phelan-McDermid Syndrome
3个月前
SLC6A20-Targeting ASO Restores NMDA Receptor Function in Autism Models, Offering New Therapeutic Strategy
2个月前
Phelan-McDermid Syndrome Prevalence Estimated at 1 in 7,300, Far Higher Than Previously Thought
2个月前
Laboratory Beagles May Bridge the Autism Drug Discovery Gap, New Perspective Argues
去年
FDA Grants Orphan Drug Designation to NeuroNOS for Phelan-McDermid Syndrome Treatment
3个月前
Texas Children's and Baylor Awarded Up to $17.25 Million to Join ARIA IMPACT Network for Autism Clinical Trials
3个月前
Brain Scans Reveal Two Distinct Biological Subtypes of Autism
9个月前
Neuren Pharmaceuticals Advances First-Ever Phase 3 Trial for Phelan-McDermid Syndrome with Promising Phase 2 Results
上个月
Marvel Biosciences' MB-204 Reverses Behavioural and Cognitive Deficits in Fragile X Mouse Model, Marking Third Preclinical ASD Success
去年
Shark-Derived Antibodies Show Promise in Targeted Cancer Therapy at UW-Madison
第 1 页,共 3 页
上一页
下一页